10 Firms Post Strong Gains Amid Wall Street Bloodbath

4. Moderna Inc. (NASDAQ:MRNA)

Shares of Moderna Inc. jumped by 11.65 percent on Tuesday, adding $4.96 to end at $47.53 each after the US reported its first bird flu death, with investor sentiment buoyed by potential demand for a new drug to protect against the virus.

The Centers for Disease Control and Prevention added there have been 66 human cases of the strain in the US in total since the start of last year.

The agency, however, said the risk of contracting the virus remains low, especially with no human transmission recorded.

In other news, Moderna is partnering with Pfizer, GSK, and CureVac to develop vaccines incorporating mRNA technology. Moderna won a $176 million award from the US government in July to develop the shot.